Navigation Links
Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed's Board of Directors
Date:2/6/2012

of Sciences (USA), a Foreign Associate of the American Academy of Arts and Sciences, as well as a Fellow of the Royal Society of London (UK). He was recently awarded the Order of Ontario and has won international recognition in the form of the Emil von Behring Prize, the King Faisal Prize for Medicine, the Gairdner Foundation International Award, the Sloan Prize of the General Motors Cancer Foundation, the Novartis Prize in Immunology and the Paul Ehrlich Prize and Ludwig Darmstaedter Prize of Germany. Dr. Mak's held the position of VP of Research at Amgen, Inc. and was Director of the Amgen Institute in Toronto from 1993-2002. His experience as a venture capitalist allows him to be an integral part of start-up companies.

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company committed to developing ENMD-2076, a selective angiogenic kinase inhibitor, for the treatment of cancer.  ENMD-2076 is currently in a multi-center Phase 2 study in ovarian cancer and in several Phase 1 studies in solid tumors, multiple myeloma, and leukemia.  Additional information about EntreMed is available on the Company's web site at www.entremed.com and in various filings with the Securities and Exchange Commission (the SEC).

About ENMD-2076

ENMD-2076 is an orally-active, Aurora A/angiogenic kinase inhibitor with a unique kinase selectivity profile and multiple mechanisms of action. ENMD-2076 has been shown to inhibit a distinct profile of angiogenic tyrosine kinase targets in addition to the Aurora A kinase. Aurora kinases are key regulators of mitosis (cell division), and are often over-expressed in human cancers. ENMD-2076 also targets the VEGFR, Flt-3 and FGFR3 kinases which have been shown to play important roles in the pathology of several cancers. ENMD-2076 has shown promising activity in Phase 1 clinical trials in solid tumor cancers, leukemia, and multiple myeloma.&
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. European Pharmaceutical and Biotech Contract Manufacturing Markets
2. Biotechnology Pharmaceutical Company Selects NewCardios QTinno for Thorough QT Trial
3. Leaders of Healthcare, Biotech and Pharmaceutical Companies Sending Proclamation to President Obama and Congress Urging Solution to Nations Healthcare Crisis
4. Aethlon Medical Discloses Availability of the Biotech Showcase™ 2012 Presentation
5. Lixte Biotechnology Holdings Announces Issuance of U.S. Patent for Agents for the Treatment of Neurodegenerative Diseases
6. GenturaDx to Present at the Biotech Showcase Conference
7. Inovio Pharmaceuticals to Present at Biotech Showcase Investor Conference
8. Trinity Biotech to Present at Sidoti & Companys Semiannual New York Micro-Cap Conference on January 9, 2012
9. Aethlon Medical Announces Biotech Showcase™ 2012 Presentation
10. Ikaria® to Present at Biotech Showcase™ 2012
11. Express Scripts HealthBridge Pharma & Biotech to Provide Specialty Pharmacy and Specialty Distribution Services for EYLEA™ (aflibercept) Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... BETHESDA, Md. , Jan. 23, 2015  Northwest Biotherapeutics, Inc. ... developing DCVax® personalized immune therapies for operable and inoperable solid ... will present at the 7 th Annual Phacilitate Immunotherapy ... NW Bio,s presentation at Phacilitate will take place on January ...
(Date:1/23/2015)... Feffer LLP ( www.hfesq.com ) is investigating potential claims ... or the "Company") (NASDAQ: ADXS ), concerning ... shareholders. On January 21, 2015, an article ... had misrepresented the clinical data for its ADXS-HPV drug ...
(Date:1/23/2015)... Inc. (ICBU) has repositioned itself as a holding company with ... in the hydroponic, hemp and medical marijuana sectors. By acquiring ... sector, and recently partnering with the Chippewa Tribe Nation to ... iMD is committing to bring its vision to the market ...
Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
... Genzyme Corp. has signed a consent decree agreeing to correct manufacturing quality violations ... federal government $175 million in unlawful profits from the sale of products ... , , , ... , , ...
... 24 The international forum "Drug Production in Afghanistan : A ... June 9 and 10, 2010, at Russia ,s initiative. , ... Heads of the key global drug control ... a conference initiated by the Russian News & Information Agency RIA Novosti. The ...
Cached Medicine Technology:Genzyme Corp. Signs Consent Decree to Correct Violations at Allston, Mass., Manufacturing Plant and Give up $175 Million in Profits 2Genzyme Corp. Signs Consent Decree to Correct Violations at Allston, Mass., Manufacturing Plant and Give up $175 Million in Profits 3Drug Production in Afghanistan: A Challenge for the International Community 2
(Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort ... TripAdvisor as the number one best large hotel for families ... world for their annual Travelers’ Choice Awards. , TripAdvisor ... website is home to millions of unbiased and honest traveler ...
(Date:1/22/2015)... 23, 2015 Angelweddingdress is a famous wedding ... its customers to follow it on Facebook, Twitter, and Pinterest. ... Day gift. Angelweddingdress draws a lottery every week. , Moreover, ... Feb. 28, 2015. Click Angelweddingdress homepage for more ...
(Date:1/22/2015)... 22, 2015 A new white paper ... and person-centeredness in the long-term care environment as well ... the continuum. The paper, “The Power of Person-Centeredness in ... and practices of the patient, resident and family experience ...
(Date:1/22/2015)... NJ (PRWEB) January 22, 2015 Joan ... and keynote speaker at the upcoming 32nd Annual ... ACCME-accredited Physicians’ Education Resource®, LLC (PER®) , shares ... would have gone undetected if she had not followed ...
(Date:1/22/2015)... Four years since the release of their debut recording ... marriage of Avasa & Matthew Love – the duo are pleased ... release through White Swan Records on February 24, 2015. , THE ... path available to all of us to walk out of the ...
Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
... deaf children with cochlear implants to help them to hear ... according to new research from UT Southwestern Medical Center auditory ... with a cochlear device and the longer he or she ... child reports and the more successful the child is in ...
... ... Lumension® Endpoint Management and Security Suite Integrates Application Control (Whitelisting) Together ... Management Model that Overcomes Traditional Operational Challenges Associated with Static Application Control ... ...
... ... ... ... ...
... ... ... ... ...
... COLUMBIA, Mo. Issues of race and gender are important ... curve in consideration of a subject that affects individuals internationally ... people. The American Sociological Association added the sociology of human ... the issue of human rights for more than 10 years. ...
... ... hospital systems and health care providers numerous solutions for training coders, admins, techs, and ... ... (KCE), a leader in health care certificate programs, has developed online continuing education ...
Cached Medicine News:Health News:Deaf children with cochlear implants report similar quality of life to that of normal-hearing kids 2Health News:Lumension Unveils Intelligent Application Whitelisting that Operationalizes a Proactive Endpoint Security Approach 2Health News:Lumension Unveils Intelligent Application Whitelisting that Operationalizes a Proactive Endpoint Security Approach 3Health News:Lumension Unveils Intelligent Application Whitelisting that Operationalizes a Proactive Endpoint Security Approach 4Health News:Lumension Unveils Intelligent Application Whitelisting that Operationalizes a Proactive Endpoint Security Approach 5Health News:Lumension Unveils Intelligent Application Whitelisting that Operationalizes a Proactive Endpoint Security Approach 6Health News:Lumension Unveils Intelligent Application Whitelisting that Operationalizes a Proactive Endpoint Security Approach 7Health News:Jiffy Lube(R) Well On Its Way to Raising Another $1 Million to Fight Heart Disease 2Health News:Jiffy Lube(R) Well On Its Way to Raising Another $1 Million to Fight Heart Disease 3Health News:Jiffy Lube(R) Well On Its Way to Raising Another $1 Million to Fight Heart Disease 4Health News:Jiffy Lube(R) Well On Its Way to Raising Another $1 Million to Fight Heart Disease 5Health News:Jiffy Lube(R) Well On Its Way to Raising Another $1 Million to Fight Heart Disease 6Health News:Jiffy Lube(R) Well On Its Way to Raising Another $1 Million to Fight Heart Disease 7Health News:Jiffy Lube(R) Well On Its Way to Raising Another $1 Million to Fight Heart Disease 8Health News:Jiffy Lube(R) Well On Its Way to Raising Another $1 Million to Fight Heart Disease 9Health News:Landacorp Teams with Milliman Care Guidelines to Improve Care Management Capabilities for Health Plans 2Health News:Landacorp Teams with Milliman Care Guidelines to Improve Care Management Capabilities for Health Plans 3Health News:Landacorp Teams with Milliman Care Guidelines to Improve Care Management Capabilities for Health Plans 4Health News:Landacorp Teams with Milliman Care Guidelines to Improve Care Management Capabilities for Health Plans 5Health News:Sociologist expands US conversation on human rights 2Health News:Kaplan Continuing Education Expands Health Care Certificate Programs 2Health News:Kaplan Continuing Education Expands Health Care Certificate Programs 3
Surgical Loupes...
... is the ultimate brain machine. This ... for best image quality and fastest ... a highly compact design. ,These features ... epilepsy, tumor and multiple sclerosis. ,In ...
Signa Profile is built on the Signa foundation to deliver speed & image quality....
... Symphony II Platelet Concentrate System is a ... of Platelet Concentrate (also referred to as ... Poor Plasma (PPP) from a small sample ... the body's natural growth factors, which are ...
Medicine Products: